Condition: Other Disorders of Vestibular Function, Bilateral · Bilateral Vestibular Deficiency (BVD) · Gentamicin Ototoxicity · Sponsor: Johns Hopkins University
Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior research has demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular implant can partially restore vestibular reflexes that normally maintain steady posture and vision; improve performance on objective measures of postural stability and gait; and improve patient-reported disability and health-related quality of life. This single-arm open-label study extends that research to evaluate outcomes for up to fifteen older adults (age 65-90 years at time of enrollment) with ototoxic or non-ototoxic bilateral vestibular hypofunction.
This description comes directly from the study's public registry record.
Kelly Lane (Study Coordinator) · 410-502-8047 · vestibularimplant@jhmi.edu
Charles C Della Santina MD, PhD, (Lead Surgeon) · 410-502-8047 · cds@jhmi.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins School of Medicine | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05676944